572 related articles for article (PubMed ID: 11085540)
21. Efficacy of ganitumab (AMG 479), alone and in combination with rapamycin, in Ewing's and osteogenic sarcoma models.
Beltran PJ; Chung YA; Moody G; Mitchell P; Cajulis E; Vonderfecht S; Kendall R; Radinsky R; Calzone FJ
J Pharmacol Exp Ther; 2011 Jun; 337(3):644-54. PubMed ID: 21385891
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of N-linked glycosylation down-regulates insulin-like growth factor-1 receptor at the cell surface and kills Ewing's sarcoma cells: therapeutic implications.
Girnita L; Wang M; Xie Y; Nilsson G; Dricu A; Wejde J; Larsson O
Anticancer Drug Des; 2000 Feb; 15(1):67-72. PubMed ID: 10888037
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of insulin-like growth factor I receptor increases the antitumor activity of doxorubicin and vincristine against Ewing's sarcoma cells.
Benini S; Manara MC; Baldini N; Cerisano V; Massimo Serra ; Mercuri M; Lollini PL; Nanni P; Picci P; Scotlandi K
Clin Cancer Res; 2001 Jun; 7(6):1790-7. PubMed ID: 11410521
[TBL] [Abstract][Full Text] [Related]
24. Zoledronic acid as a new adjuvant therapeutic strategy for Ewing's sarcoma patients.
Odri GA; Dumoucel S; Picarda G; Battaglia S; Lamoureux F; Corradini N; Rousseau J; Tirode F; Laud K; Delattre O; Gouin F; Heymann D; Redini F
Cancer Res; 2010 Oct; 70(19):7610-9. PubMed ID: 20841471
[TBL] [Abstract][Full Text] [Related]
25. Intratumor murine interleukin-12 gene therapy suppressed the growth of local and distant Ewing's sarcoma.
Jia SF; Duan X; Worth LL; Guan H; Kleinerman ES
Cancer Gene Ther; 2006 Oct; 13(10):948-57. PubMed ID: 16763609
[TBL] [Abstract][Full Text] [Related]
26. Neuroectodermal differentiation in "extraskeletal Ewing's sarcoma".
Kudo M
Acta Pathol Jpn; 1989 Dec; 39(12):795-802. PubMed ID: 2560312
[TBL] [Abstract][Full Text] [Related]
27. Mitogenic and anti-proliferative signals for neural crest cells and the neurogenic action of TGF-beta1.
Zhang JM; Hoffmann R; Sieber-Blum M
Dev Dyn; 1997 Mar; 208(3):375-86. PubMed ID: 9056641
[TBL] [Abstract][Full Text] [Related]
28. [Clinico-pathologic study of Ewing's sarcomas of bone and soft tissue and peripheral primitive neuroectodermal tumors].
Na J; Li J; Fang Z
Zhonghua Zhong Liu Za Zhi; 1998 Jan; 20(1):71-3. PubMed ID: 10921066
[TBL] [Abstract][Full Text] [Related]
29. Suppression of Ewing's sarcoma tumor growth, tumor vessel formation, and vasculogenesis following anti vascular endothelial growth factor receptor-2 therapy.
Zhou Z; Bolontrade MF; Reddy K; Duan X; Guan H; Yu L; Hicklin DJ; Kleinerman ES
Clin Cancer Res; 2007 Aug; 13(16):4867-73. PubMed ID: 17699866
[TBL] [Abstract][Full Text] [Related]
30. In vitro test-system for chemo- and thermosensitivity: an analysis of survival fractions and cell-cycle distributions in human Ewing's sarcomas as a modelfor tumors in pediatric oncology.
Debes A; Rommel F; Breise M; Willers R; Göbel U; Wessalowski R
Klin Padiatr; 2002; 214(4):223-9. PubMed ID: 12165906
[TBL] [Abstract][Full Text] [Related]
31. [Cooperative Ewing's Sarcoma Studies 81/86: pathologico-anatomic and immunohistochemical findings and differential diagnosis of Ewing sarcoma].
Schmidt D; Harms D
Klin Padiatr; 1988; 200(3):236-42. PubMed ID: 3062261
[TBL] [Abstract][Full Text] [Related]
32. Antitumor activity of the insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 in musculoskeletal tumors.
Scotlandi K; Manara MC; Nicoletti G; Lollini PL; Lukas S; Benini S; Croci S; Perdichizzi S; Zambelli D; Serra M; García-Echeverría C; Hofmann F; Picci P
Cancer Res; 2005 May; 65(9):3868-76. PubMed ID: 15867386
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-12 up-regulates Fas expression in human osteosarcoma and Ewing's sarcoma cells by enhancing its promoter activity.
Zhou Z; Lafleur EA; Koshkina NV; Worth LL; Lester MS; Kleinerman ES
Mol Cancer Res; 2005 Dec; 3(12):685-91. PubMed ID: 16380506
[TBL] [Abstract][Full Text] [Related]
34. Antitumor effect of nutrient synergy on human osteosarcoma cells U-2OS, MNNG-HOS and Ewing's sarcoma SK-ES.1.
Roomi MW; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
Oncol Rep; 2005 Feb; 13(2):253-7. PubMed ID: 15643507
[TBL] [Abstract][Full Text] [Related]
35. beta-Adrenergic receptors in pediatric tumors: uncoupled beta 1-adrenergic receptor in Ewing's sarcoma.
Whitsett JA; Burdsall J; Workman L; Hollinger B; Neely J
J Natl Cancer Inst; 1983 Oct; 71(4):779-86. PubMed ID: 6312152
[TBL] [Abstract][Full Text] [Related]
36. Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: correlations with local tumor extent and prognosis.
Rutkowski P; Kamińska J; Kowalska M; Ruka W; Steffen J
J Surg Oncol; 2003 Nov; 84(3):151-9. PubMed ID: 14598359
[TBL] [Abstract][Full Text] [Related]
37. Primary peripheral primitive neuroectodermal tumor/Ewing's tumor of the testis in a 46-year-old man-differential diagnosis and review of the literature.
Heikaus S; Schaefer KL; Eucker J; Hogrebe E; Danebrock R; Wai DH; Krenn V; Gabbert HE; Poremba C
Hum Pathol; 2009 Jun; 40(6):893-7. PubMed ID: 19269015
[TBL] [Abstract][Full Text] [Related]
38. Role of basic FGF and oxygen in control of proliferation, survival, and neuronal differentiation in carotid body chromaffin cells.
Nurse CA; Vollmer C
Dev Biol; 1997 Apr; 184(2):197-206. PubMed ID: 9133430
[TBL] [Abstract][Full Text] [Related]
39. Effects of basic fibroblast growth factor on the differentiation, growth, and viability of a new human medulloblastoma cell line (UM-MB1).
Kenigsberg RL; Hong Y; Yao H; Lemieux N; Michaud J; Tautu C; Théorêt Y
Am J Pathol; 1997 Sep; 151(3):867-81. PubMed ID: 9284836
[TBL] [Abstract][Full Text] [Related]
40. Ultrastructure of the Ewing's sarcoma family of tumors.
Suh CH; Ordóñez NG; Hicks J; Mackay B
Ultrastruct Pathol; 2002; 26(2):67-76. PubMed ID: 12036094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
